Ligand validation:2Z24

DOR: (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID

DOR is a Ligand Of Interest in 2Z24 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Z24_DOR_A_1410	81%	19%	0.118	0.97	0.9	2.54	-	6	1	0	100%	1
2Z26_DOR_B_1430	96%	27%	0.066	0.973	1.02	1.92	-	4	0	0	100%	0.5
2Z28_DOR_A_1410	86%	21%	0.082	0.95	1.04	2.26	-	4	1	0	100%	1
2Z29_DOR_A_1410	78%	15%	0.11	0.953	1.02	2.68	-	3	1	0	100%	1
2Z27_DOR_A_1410	74%	26%	0.13	0.959	1.07	1.91	-	4	1	0	100%	1
2Z25_DOR_A_1410	73%	23%	0.131	0.958	1.17	1.99	1	4	1	0	100%	1
6ET4_DOR_A_502	99%	5%	0.048	0.983	2.15	3.09	5	6	0	0	100%	1
6GK0_DOR_A_502	98%	10%	0.065	0.988	1.83	2.48	4	6	0	0	100%	1
4C6D_DOR_A_2822	98%	21%	0.058	0.98	1.39	1.93	1	3	4	0	100%	0.45
4C6I_DOR_A_2830	98%	24%	0.062	0.982	1.4	1.7	1	1	3	0	100%	0.41
2E68_DOR_B_2353	97%	26%	0.059	0.976	1.04	1.92	-	4	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.